Assessing chromosomal abnormalities in leukemias by imaging flow cytometry.

Area of Science:

• Oncology
• Cytogenetics
• Flow Cytometry

Background:

• Chromosome analysis is crucial for leukemia diagnosis and prognosis.
• Traditional methods like karyotyping and FISH have limitations in throughput and specificity.
• Flow cytometry offers a high-throughput automated approach for cellular analysis.

Purpose of the Study:

• To introduce and evaluate imaging flow cytometry combined with immunophenotyping for cytogenomic analysis in oncology.
• To demonstrate the application of this technique for detecting chromosomal abnormalities in hematological malignancies.
• To highlight its potential for sensitive disease monitoring and solid tumor analysis.

Main Methods:

• Utilizing imaging flow cytometry to analyze chromosomal content within specific cell populations.
• Integrating immunophenotyping to identify and isolate leukemic cells for targeted analysis.
• Applying fluorescent in situ hybridization (FISH) probes for specific chromosome detection.

Main Results:

• The technique successfully identifies and enumerates specific chromosomes and regions of interest within targeted cell types.
• It enables the detection of aneuploidy and structural chromosomal defects (deletions, translocations) in leukemic cells.
• Demonstrated a limit of detection as low as 1 abnormal cell in 100,000, suitable for minimal residual disease monitoring.

Conclusions:

• Imaging flow cytometry with immunophenotyping provides a powerful, high-throughput tool for cytogenomic analysis in hematological malignancies.
• This method expands the role of flow cytometry in oncology, offering enhanced diagnostic and prognostic capabilities.
• The technique shows promise for sensitive disease monitoring, detecting clonal evolution, and analyzing solid tumors.